My article in MJBizDaily, published on July 16, 2020, looking at the decline in sales estimates despite already declining 14-21% going into earnings. Valuations stood at 3.5X Sales, and 8.0X EBITDA for the US stocks.
Investment Analysis and Valuation of the Cannabis Industry